Abstract:Objective Objectives To investigate the possible mechanism of procyanidin (PC) in regulating lipid metabolism through gut microbiota. Methods Male adult SD rats and Meriones unguiculatus were fed with basal forage for one week, of which the serum samples were collected and determined for total cholesterol (TC) level. These animals were divided into six groups according to their TC levels and bodyweights. The animals in normal control group were fed with common forage, while those in the other five groups with high lipid forage. The animals in three test groups were treated with PC by oral route at low (25 mg/kg), moderate (100 mg/kg) and high (150 mg/kg) dosages respectively, while those in positive control group with Fenofibrate at a dosage of 80 mg/kg, once a day for 8 (rats) and 2 (M. unguiculatus ) weeks. The rats were killed at end of 8 weeks, while M. unguiculatus at end of 2 weeks, of which serum samples were collected. However, the fecal samples of animals within 72 h before being killed were collected. The TC, triglyceride (TG), high density lipoproteinprotein cholesterol (HUlAl), low-density lipoprotein cholesterol (LDIy-C) and total bile acid (TBA) levels in sera were determined by full-automatic biochemical analyzer, while the TBA level in feces by enzymalic cycling assay kit, and the lecithin cholesterol acyl transferase (LCAT) activity by two-step double antibody sandwich ELISA. The histopathology of killed animals was observed. The genomic DNAs were extracted from bacteria in small intestines and intestinum caecum of the animals, and analyzed for the changes of predominant bacteria of gut microbiota by PCR-denaturing gradient gel electrophoresis (DGGE). Results The TC and TG levels of animals in model control group were significandy higher than those in normal control group (P< 0. 05), indicating successful establishment of animal model of hyperlipidemia. As compared with those in model control group, the serum TC, TG, LDL-C and TBA levels in three test groups decressed significantly, while LCAT activity and fecal TBA level increased significantly (each P < 0. 05). The liver lesion, hepatic cell swelling and degeneration in three test groups significantly improved. DGGE and imaging showed that the diversity of predominant bacteria from gut microbiota in three test groups increased significantly, while decreased significantly with the increasing dosage of TC. The bacterial profile of M. unguiculatus treated with 25 mg/kg PC was similar to that in model control group. However, the diversity of gut microbiota decreased significantly, and the predominant bacteria showed an obvious tendency of restoration, in 100 and 150 mg/kg group. Conclusion The predominant bacterial profile of gut microbiota of experimental animal model showed an obviouse tendency of restoration after intervention by PC and dosages of 100 and 150 mg/kg, indicating the PC might regulate the lipid metabolism via gut microbiota pathway.

Metabolomics Reveals Hyperlipidemic Biomarkers and Antihyperlipidemic Effect of Poria Cocos

Lipidomics Biomarkers of Diet-Induced Hyperlipidemia and Its Treatment with Poria Cocos.

The anti-hyperlipidemic effects of Poria cocos (Schw.) Wolf extract: Modulating cholesterol homeostasis in hepatocytes via PPARα pathway

Procyanidin regulates lipid metabolism through gut microbiota

The Antihyperlipidemic Effect of Fu-Ling-Pi is Associated with Abnormal Fatty Acid Metabolism As Assessed by UPLC-HDMS-based Lipidomics

Integrating metabolomics with network pharmacology to reveal the mechanism of Poria cocos in hyperuricemia treatment

Metabolomic profile of plasma approach to investigate the mechanism of Poria cocos oligosaccharides attenuated LPS-induced acute lung injury in mice

Renal Metabolic Profiling of Early Renal Injury and Renoprotective Effects of Poria Cocos Epidermis Using UPLC Q-TOF/HSMS/MSE.

Regulation of gut microbiota and intestinal metabolites by Poria cocos oligosaccharides improves glycolipid metabolism disturbance in high-fat diet-fed mice

Efficacy of Poria cocos and Alismatis rhizoma against diet-induced hyperlipidemia in rats based on transcriptome sequencing analysis

In vivo identification of bioactive components of Poria cocos for adjusting mitochondria against metabolic dysfunction-associated fatty liver disease

Structural characterization of Poria cocos oligosaccharides and their effects on hepatic metabolome in high-fat diet-fed mice

Integrative analysis reveals the anti-obesity roles of Poria cocos polysaccharides through beneficial effects on gut microbiota

The hypolipidemic study of total triterpenic compounds from sclerotia of Poria Cocos

Integrated 16S rDNA, metabolomics, and TNF-α/NF-κB signaling pathway analyses to explain the modulatory effect of Poria cocos aqueous extract on anxiety-like behavior

Three main metabolites from Wolfiporia cocos (F. A. Wolf) Ryvarden & Gilb regulate the gut microbiota in mice: A comparative study using microbiome-metabolomics

Poria cocus Wolf Extract Ameliorates Hepatic Steatosis through Regulation of Lipid Metabolism, Inhibition of ER Stress, and Activation of Autophagy via AMPK Activation

Identification of Triterpene Acids in Poria Cocos Extract As Bile Acid Uptake Transporter Inhibitors

Integration of network pharmacology, UHPLC-Q exactive orbitrap HRMS technique and metabolomics to elucidate the active ingredients and mechanisms of compound danshen pills in treating hypercholesterolemic rats

The substance basis of Poria ameliorates hypothyroidism other than hyperthyroidism based on proteomics and metabolomics

1H-NMR and MS Based Metabolomics Study of the Intervention Effect of Curcumin on Hyperlipidemia Mice Induced by High-Fat Diet